Article Figures & Tables
Tables
- Table 1: Demographic information for patients who responded to the survey at Stollery Children’s Hospital and the Children’s Hospital of Eastern Ontario, February to July 2007
Characteristic Stollery CHEO Both sites, no. (%) or mean ± SD n* No. (%) or mean
± SDn* No. (%) or mean
± SDPatients Age, mean ± SD 145 7.0 ± 5.6 31 8.6 ± 5.0 7.3 ± 5.5 Sex, male 144 81 (56.3) 31 19 (61.3) 100 (57.1) Ethnicity 136 31 White 54 (39.7) 12 (38.7) 66 (39.5) Canadian/French Canadian 50 (36.8) 14 (45.2) 64 (38.3) Aboriginal/Native/Metis/Inuit 18 (13.2) 4 (12.9) 22 (13.2) East Indian 9 (6.6) 1 (3.2) 10 (6.0) Asian 7 (5.1) 1 (3.2) 8 (4.8) Black 3 (2.2) 0 3 (1.8) Middle Eastern 5 (3.7) 0 5 (3.0) Latin American/Mexican 4 (2.9) 1 (3.2) 5 (3.0) Health status† 145 31 Excellent 33 (22.8) 4 (12.9) 37 (21.0) Very good 64 (44.1) 10 (32.3) 74 (42.0) Good 32 (22.1) 14 (45.2) 46 (26.1) Fair 15 (10.3) 2 (6.5) 17 (9.7) Poor 1 (0.7) 1 (3.2) 2 (1.1) Time since diagnosis, mo 142 31 0–3 31 (21.8) 4 (12.9) 35 (20.2) > 3–6 11 (7.7) 1 (3.2) 12 (6.9) > 6–12 14 (9.9) 3 (9.7) 17 (9.8) > 12 86 (60.6) 23 (74.2) 109 (63.0) Use of CAM in lifetime, yes‡ 145 93 (64.1) 31 11 (35.5) 104 (59.1) Timing of CAM use 82 11 Before conventional medicine 9 (11.0) 1 (9.1) 10 (10.8) Concurrent with conventional medicine 34 (41.5) 4 (36.4) 38 (40.9) After conventional medicine was successful 0 0 0 After conventional medicine failed 2 (2.4) 0 2 (2.2) Instead of conventional medicine 5 (6.1) 0 5 (5.4) Note: CAM = complementary and alternative medicine, CEGEP = Collège d’enseignement général et professionnel, CHEO = Children’s Hospital of Eastern Ontario, SD = standard deviation. *Number of valid responses. †Significantly higher at CHEO than Stollery (p = 0.008). ‡Significantly higher at Stollery than CHEO (p = 0.003). §Significantly higher at CHEO than Stollery (p = 0.04). ¶Significantly higher at CHEO than Stollery (p = 0.01).
- Table 2: Demographic information for patients and caregivers who responded to the survey at Stollery Children’s Hospital and the Children’s Hospital of Eastern Ontario, February to July 2007
Characteristic Stollery CHEO Both sites, no. (%) or mean ± SD n* No. (%) or mean
± SDn* No. (%) or mean
± SDAge, mean ± SD 141 36.8 ± 9.2 31 40 ± 7.2 37.4 ± 8.9 Sex, male 143 22 (15.4) 30 5 (16.7) 27 (15.6) Highest completed level of education 140 30 No formal education 0 0 0 Primary school only 3 (2.1) 0 3 (1.8) Secondary school 44 (31.4) 8 (26.7) 52 (30.6) Registered apprentice or trade 7 (5.0) 1 (3.3) 8 (4.7) College, CEGEP or other non-university 41 (29.3) 9 (30.3) 50 (29.4) University, without a degree 14 (10.0) 1 (3.3) 15 (8.8) University graduate§ 27 (19.3) 11 (36.7) 38 (22.4) Other 4 (2.9) 0 4 (2.4) Annual household income, $ 128 30 < 10 000 3 (2.3) 0 3 (1.9) 10 000–19 999 10 (7.8) 2 (6.7) 12 (7.6) 20 000–39 999 20 (15.6) 2 (6.7) 22 (13.9) 40 000–79 999 41 (32.0) 11 (36.7) 52 (32.9) ≥ 80 000 54 (42.2) 15 (50.0) 69 (43.7) Availability of insurance for CAM 145 55 (38.7) 31 21 (67.7) 76 (43.9) Use of CAM in lifetime, yes 145 105 (72.4) 31 22 (71.0) 127 (72.2) Note: CAM = complementary and alternative medicine, CEGEP = Collège d’enseignement général et professionnel, CHEO = Children’s Hospital of Eastern Ontario, SD = standard deviation. *Number of valid responses. †Significantly higher at CHEO than Stollery (p = 0.008). ‡Significantly higher at Stollery than CHEO (p = 0.003). §Significantly higher at CHEO than Stollery (p = 0.04). ¶Significantly higher at CHEO than Stollery (p = 0.01).
- Table 3: Complementary and alternative medicine products and practices commonly used by patients seen in pediatric cardiology clinics at Stollery Children’s Hospital and the Children’s Hospital of Eastern Ontario and their perceived helpfulness.
Product or practice Current use,
no. (%)Ever used, no. (%) Perceived helpful, no. (%) n* Yes No Maybe Product n = 68 n = 95 Vitamins and minerals 56 (82.4) 86 (90.5) Multivitamin 48 (70.6) 72 (75.8) 72 35 (48.6) 4 (5.6) 33 (45.8) Vitamin C 15 (22.1) 31 (32.6) 29 19 (65.5) 1 (3.4) 9 (31.0) Calcium 9 (13.2) 15 (15.8) 13 8 (61.5) 1 (7.7) 4 (30.8) Vitamin B 2 (2.9) 12 (12.6) 10 5 (50.0) 1 (10.0) 4 (40.0) Herbals 8 (11.8) 28 (29.5) Echinacea 3 (4.4) 17 (17.9)† 16 10 (62.5) 1 (6.3) 5 (31.3) Homeopathics 12 (17.6) 36 (37.9) Cold remedy 8 (11.8) 21 (22.1) 18 16 (88.9) 1 (5.6) 1 (5.6) Teething remedy 2 (2.9) 13 (13.7) 13 11 (84.6) 0 (0) 2 (15.4) Miscellaneous 17 (25.0) 37 (38.9) Fish oil/omega 3 fatty acids 8 (11.8)† 16 (16.8) 13 2 (15.4) 0 11 (84.6) Acidophilus/probiotics 6 (8.8)† 14 (14.7)† 12 7 (58.3) 1 (8.3) 4 (33.3) Practice n = 40 n = 65 Massage 15 (37.5) 26 (40.0) 23 21 (91.3) 0 2 (8.7) Faith healing 10 (25.0) 16 (24.6) 12 12 (100.0) 0 0 Chiropractic 8 (20.0) 21 (32.3) 20 14 (70.0) 3 (15.0) 3 (15.0) Aromatherapy 6 (15.0) 12 (18.5) 11 8 (72.7) 0 3 (27.3) Aboriginal healing 3 (7.5) 7 (10.8) 6 5 (83.3) 0 (0) 1 (16.7) *Number of valid responses. †Significant difference between the 2 sites (p < 0.05).
- Table 4: Concurrent use of conventional prescription drugs and complementary and alternative medicine by patients seen in pediatric cardiology clinics at Stollery Children’s Hospital and the Children’s Hospital of Eastern Ontario.
Conventional drug No. of users (%)
n = 32CAM products used concurrently No. CAM users Anticoagulants 3 (9.4) Vitamins and minerals 3 Miscellaneous 1 Antihypertensive agents* 10 (31.3) Vitamins and minerals 8 Herbals 1 Miscellaneous 4 Homeopathy 2 Beta-blockers 3 (9.4) Vitamins and minerals 2 Homeopathy 1 Diuretic agents 9 (28.1) Vitamins and minerals 7 Herbals 1 Miscellaneous 2 Cardiac glycosides 3 (9.4) Vitamins and minerals 1 Herbals 1 Homeopathy 1 Antithrombotic agents 2 (6.3) Vitamins and minerals 2 Miscellaneous 1 Hypothyroid agents 3 (9.4) Vitamins and minerals 1 Homeopathy 1 Antibiotics 6 (18.8) Vitamins and minerals 3 Herbals 1 Miscellaneous 2 Other† 15 (46.9) Vitamins and minerals 11 Herbals 1 Miscellaneous 5 Homeopathy 3 Note: CAM = complementary and alternative medicine. *Includes calcium-channel blockers and angiotensin-converting-enzyme inhibitors. †Proton-pump inhibitors (2), domperidone (1), anticonvulsants (3), morphine (1), quetiapine (1), anti-asthmatic agents (2), epinephrine (1), sildenafil (1), psychostimulants (2), antidepressants (1), ursodeoxycholic acid (1), antihistamines (1), clonidine (1), laxatives (1), chemotherapeutics (2), glycopyrrolate (1), insulin (2).